Dongyi He
Professor
Department of Rheumatology
Institute of Integrated Bioinformedicine and Translational Science
Hong Kong
Biography
Name: He Dongyi Academic qualifications: 1986.9-1989.7 B. Med. Shanghai Second Medical University, Shanghai, China 1997.9-2000.7 M. Med. Department of Chinese Internal Medicine, Shanghai University of Chinese Medicine, China 2005.9-2008.7 M.D. Department of Integrated Traditional Chinese and Western Medicine, Shanghai University of Chinese Medicine, China Previous academic positions held: 1989.7-1998.12 Resident Department of Internal Medicine, Guanghua Hospital of Integrated Traditional Chinese and Western Medicine, Shanghai, China 1999.1-2002.6 Physician-in-Charge Department of Rheumatology, Guanghua Hospital of Integrated Traditional Chinese and Western Medicine, Shanghai, China 2002.7-2007.9 Deputy Director Department of Rheumatology, Guanghua Hospital of Integrated Traditional Chinese and Western Medicine, Shanghai, China Present academic position: 2007.10- Director Department of Rheumatology, Guanghua Hospital of Integrated Traditional Chinese and Western Medicine, Shanghai, China 2011.7- Ph.D. Supervisor Shanghai University of Traditional Chinese Medicine, Shanghai, China
Research Interest
Integrated Traditional Chinese and Western Medicine therapy research in rheumatoid arthritis
Publications
-
Fan LY, He DY, Wang Q, Zong M, Zhang H, Yang L, Sun LS. Citrullinated vimentin stimulates proliferation, pro-inflammatory cytokine secretion, and PADI4 and RANKL expression of fibroblast-like synoviocytes in rheumatoid arthritis. Scandinavian journal of rheumatology. 2012 Oct 1;41(5):354-8.
-
Zhu S, Pan W, Song X, Liu Y, Shao X, Tang Y, Liang D, He D, Wang H, Liu W, Shi Y. The microRNA miR-23b suppresses IL-17-associated autoimmune inflammation by targeting TAB2, TAB3 and IKK-[alpha]. Nature medicine. 2012 Jul 1;18(7):1077-86.
-
He D, Bai F, Zhang S, Jiang T, Shen J, Zhu Q, Yue T, Shao L, Gao Y, Feng Y, Weng X. High incidence of tuberculosis infection in rheumatic diseases and impact for chemoprophylactic prevention of tuberculosis activation during biologics therapy. Clinical and Vaccine Immunology. 2013 Jun 1;20(6):842-7.
-
Nie H, Zheng Y, Li R, Guo TB, He D, Fang L, Liu X, Xiao L, Chen X, Wan B, Chin YE. Phosphorylation of FOXP3 controls regulatory T cell function and is inhibited by TNF-[alpha] in rheumatoid arthritis. Nature medicine. 2013 Mar 1;19(3):322-8.
